These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 1611696)

  • 41. Highly specific inhibition of human immunodeficiency virus type 1 by a novel 6-substituted acyclouridine derivative.
    Baba M; Tanaka H; De Clercq E; Pauwels R; Balzarini J; Schols D; Nakashima H; Perno CF; Walker RT; Miyasaka T
    Biochem Biophys Res Commun; 1989 Dec; 165(3):1375-81. PubMed ID: 2575380
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inhibition of infection with human immunodeficiency virus type 1 by sulfated gangliosides.
    Handa A; Hoshino H; Nakajima K; Adachi M; Ikeda K; Achiwa K; Itoh T; Suzuki Y
    Biochem Biophys Res Commun; 1991 Feb; 175(1):1-9. PubMed ID: 1998495
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Adenallene and cytallene: acyclic-nucleoside analogues that inhibit replication and cytopathic effect of human immunodeficiency virus in vitro.
    Hayashi S; Phadtare S; Zemlicka J; Matsukura M; Mitsuya H; Broder S
    Proc Natl Acad Sci U S A; 1988 Aug; 85(16):6127-31. PubMed ID: 3261865
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lignified materials as medicinal resources. V. Anti-HIV (human immunodeficiency virus) activity of some synthetic lignins.
    Nakashima H; Murakami T; Yamamoto N; Naoe T; Kawazoe Y; Konno K; Sakagami H
    Chem Pharm Bull (Tokyo); 1992 Aug; 40(8):2102-5. PubMed ID: 1423763
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inhibition of human immunodeficiency virus type 1 replication and cytopathicity by synthetic soluble catecholamine melanins in vitro.
    Montefiori DC; Modliszewski A; Shaff DI; Zhou J
    Biochem Biophys Res Commun; 1990 Apr; 168(1):200-5. PubMed ID: 2327999
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibitory effect of new antibiotic, pradimincin A on infectivity, cytopathic effect and replication of human immunodeficiency virus in vitro.
    Tanabe A; Nakashima H; Yoshida O; Yamamoto N; Tenmyo O; Oki T
    J Antibiot (Tokyo); 1988 Nov; 41(11):1708-10. PubMed ID: 3198504
    [No Abstract]   [Full Text] [Related]  

  • 47. [Interferonogenic activity of low-molecular compounds of plant origin].
    Ershov FI; Saĭitkulov AM; Tazulakhova EB
    Vopr Virusol; 1988; 33(6):750-2. PubMed ID: 2470203
    [No Abstract]   [Full Text] [Related]  

  • 48. Evaluation of the safety of blood products with respect to human immunodeficiency virus infection by using an HTLV-I-infected cell line (SKT-1B).
    Koito A; Shirono K; Suto H; Matsushita S; Hattori T; Takatsuki K
    Jpn J Cancer Res; 1987 Apr; 78(4):365-71. PubMed ID: 2884206
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A new fluoroquinolone derivative exhibits inhibitory activity against human immunodeficiency virus type 1 replication.
    Kashiwase H; Momota K; Ohmine T; Komai T; Kimura T; Katsube T; Nishigaki T; Kimura S; Shimada K; Furukawa H
    Chemotherapy; 1999; 45(1):48-55. PubMed ID: 9876209
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cells surviving infection by human immunodeficiency virus type 1: vif or vpu mutants produce non-infectious or markedly less cytopathic viruses.
    Kishi M; Nishino Y; Sumiya M; Ohki K; Kimura T; Goto T; Nakai M; Kakinuma M; Ikuta K
    J Gen Virol; 1992 Jan; 73 ( Pt 1)():77-87. PubMed ID: 1730943
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Novel, negatively charged, human serum albumins display potent and selective in vitro anti-human immunodeficiency virus type 1 activity.
    Jansen RW; Schols D; Pauwels R; De Clercq E; Meijer DK
    Mol Pharmacol; 1993 Nov; 44(5):1003-7. PubMed ID: 7902528
    [TBL] [Abstract][Full Text] [Related]  

  • 52. New soluble-formazan assay for HIV-1 cytopathic effects: application to high-flux screening of synthetic and natural products for AIDS-antiviral activity.
    Weislow OS; Kiser R; Fine DL; Bader J; Shoemaker RH; Boyd MR
    J Natl Cancer Inst; 1989 Apr; 81(8):577-86. PubMed ID: 2495366
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Polyanion inhibitors of human immunodeficiency virus and other viruses. 6. Micelle-like anti-HIV polyanionic compounds based on a carbohydrate core.
    Leydet A; Jeantet-Segonds C; Bouchitté C; Moullet C; Boyer B; Roque JP; Witvrouw M; Este J; Snoeck R; Andrei G; De Clercq E
    J Med Chem; 1997 Jan; 40(3):350-6. PubMed ID: 9022801
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Interpretation of data on the use of 5'-nucleotidase inhibition to preserve the cardioplegically arrested rabbit heart.
    Schmit TJ; Gingell RL
    J Thorac Cardiovasc Surg; 1993 Sep; 106(3):561-3. PubMed ID: 8361203
    [No Abstract]   [Full Text] [Related]  

  • 55. Fuchsin acid selectively inhibits human immunodeficiency virus (HIV) replication in vitro.
    Baba M; Schols D; Pauwels R; Balzarini J; De Clercq E
    Biochem Biophys Res Commun; 1988 Sep; 155(3):1404-11. PubMed ID: 3178818
    [TBL] [Abstract][Full Text] [Related]  

  • 56. New substances against human immunodeficiency virus: sulfated 5'-nucleotidase inhibitory polyphenols.
    Toukairin T; Uchino K; Mizuno T; Nakashima H; Yamamoto N; Ogawara H
    Chem Pharm Bull (Tokyo); 1992 Mar; 40(3):802-4. PubMed ID: 1611696
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The growth inhibition of Streptococcus mutans by 5'-nucleotidase inhibitors from Areca catechu L.
    Iwamoto M; Uchino K; Toukairin T; Kawaguchi K; Tatebayashi T; Ogawara H; Tonosaki Y
    Chem Pharm Bull (Tokyo); 1991 May; 39(5):1323-4. PubMed ID: 1914009
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inhibitory effect of tannic acid sulfate and related sulfates on infectivity, cytopathic effect, and giant cell formation of human immunodeficiency virus.
    Mizuno T; Uchino K; Toukairin T; Tanabe A; Nakashima H; Yamamoto N; Ogawara H
    Planta Med; 1992 Dec; 58(6):535-9. PubMed ID: 1484893
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhibition of human immunodeficiency viral replication by tannins and related compounds.
    Nakashima H; Murakami T; Yamamoto N; Sakagami H; Tanuma S; Hatano T; Yoshida T; Okuda T
    Antiviral Res; 1992 May; 18(1):91-103. PubMed ID: 1416904
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Synthesis of an inhibitor of human immunodeficiency virus infection.
    Hatanaka K; Yoshida T; Uryu T; Yoshida O; Nakashima H; Yamamoto N; Mimura T; Kaneko Y
    Jpn J Cancer Res; 1989 Feb; 80(2):95-8. PubMed ID: 2498253
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.